Literature DB >> 22318487

[Histopathological aspects of pulmonary hypertension].

D Jonigk1, M M Hoeper, H Kreipe, F Länger.   

Abstract

In pulmonary hypertension there is a discrepancy between the dramatic but unspecific clinical presentation and the remodeling of mostly only limited segments of the vascular compartment of pulmonary parenchyma. Clinical diagnosis relies for the most part on invasive procedures, such as right heart catheterization. Therefore, morphology can provide a reliable etiopathogenetic classification only in close cooperation with the clinical partner disciplines involved. Moreover, the histopathological approach requires intimate knowledge of the vascular anatomy of the lungs and assessment of the parenchyma to be able to diagnose pulmonary hypertension and differentiate between the various types.

Entities:  

Mesh:

Year:  2012        PMID: 22318487     DOI: 10.1007/s00292-011-1560-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  16 in total

Review 1.  Pulmonary hypertension in sarcoidosis: a review.

Authors:  Tamera J Corte; Athol U Wells; Andrew G Nicholson; David M Hansell; Stephen J Wort
Journal:  Respirology       Date:  2011-01       Impact factor: 6.424

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  Gregory Piazza; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2011-01-27       Impact factor: 91.245

Review 3.  Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.

Authors:  Francois Haddad; Kristina Kudelko; Olaf Mercier; Bojan Vrtovec; Roham T Zamanian; Vinicio de Jesus Perez
Journal:  Prog Cardiovasc Dis       Date:  2011 Sep-Oct       Impact factor: 8.194

4.  Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment.

Authors:  Danny Jonigk; Heiko Golpon; Clemens L Bockmeyer; Lavinia Maegel; Marius M Hoeper; Jens Gottlieb; Nils Nickel; Kais Hussein; Ulrich Maus; Ulrich Lehmann; Sabina Janciauskiene; Tobias Welte; Axel Haverich; Johanna Rische; Hans Kreipe; Florian Laenger
Journal:  Am J Pathol       Date:  2011-05-11       Impact factor: 4.307

Review 5.  Pulmonary hypertension in patients with interstitial lung diseases.

Authors:  Jay H Ryu; Michael J Krowka; Patricia A Pellikka; Karen L Swanson; Michael D McGoon
Journal:  Mayo Clin Proc       Date:  2007-03       Impact factor: 7.616

6.  Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

Authors:  Angelo M Taveira-DaSilva; Olanda M Hathaway; Vandana Sachdev; Yukitaka Shizukuda; Charles W Birdsall; Joel Moss
Journal:  Chest       Date:  2007-09-21       Impact factor: 9.410

7.  Definition, classification, and epidemiology of pulmonary arterial hypertension.

Authors:  Marius M Hoeper
Journal:  Semin Respir Crit Care Med       Date:  2009-07-24       Impact factor: 3.119

Review 8.  Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.

Authors:  Emmanuel Weitzenblum; Ari Chaouat; Matthieu Canuet; Romain Kessler
Journal:  Semin Respir Crit Care Med       Date:  2009-07-24       Impact factor: 3.119

9.  Idiopathic pulmonary veno-occlusive disease.

Authors:  Mai Iwaki; Kazuyoshi Imaizumi; Toyoharu Yokoi; Masashi Kondo; Katsuhiro Kawaguchi; Yoshinori Hasegawa
Journal:  Intern Med       Date:  2009-08-03       Impact factor: 1.271

10.  Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline.

Authors:  Leo C Ginns; David H Roberts; Eugene J Mark; John L Brusch; Jennifer J Marler
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

View more
  1 in total

1.  [Aberrant reparative tissue remodeling: histopathology and molecular pathology].

Authors:  D Jonigk
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.